Lin BioScience, Inc. (TPEX:6696)
411.50
-9.00 (-2.14%)
Apr 29, 2026, 1:58 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 34.79 billion as of April 29, 2026. Its market cap has increased by 214.00% in one year.
Market Cap
34.79B
Enterprise Value
32.10B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
411.50
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 34.79B, an increase of 1,092.89%. That is a compound annual growth rate of 38.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 24.92B |
| Pell Bio-Med Technology | 49.57B |
| Sunmax Biotechnology | 21.16B |
| Lumosa Therapeutics | 21.10B |
| AP Biosciences | 15.96B |
| Locus Cell | 15.88B |
| Medigen Vaccine Biologics | 15.65B |
| Polaris Group | 15.05B |